These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1135 related items for PubMed ID: 15327491
1. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C, Prakash S, Sandweiss L, Bose S. Breast J; 2004; 10(5):392-7. PubMed ID: 15327491 [Abstract] [Full Text] [Related]
2. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092 [Abstract] [Full Text] [Related]
3. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group. Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [Abstract] [Full Text] [Related]
4. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Kwon Y, Ro J, Kang HS, Kim SK, Hong EK, Khang SK, Gong G, Ro JY. Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771 [Abstract] [Full Text] [Related]
5. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U. J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [Abstract] [Full Text] [Related]
6. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact. Dabbs DJ, Fung M, Johnson R. Breast J; 2004 Jun; 10(3):190-4. PubMed ID: 15125743 [Abstract] [Full Text] [Related]
7. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer. Nogi H, Suzuki M, Kamio M, Kato K, Kawase K, Toriumi Y, Takeyama H, Fukushima H, Morikawa T, Uchida K. Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353 [Abstract] [Full Text] [Related]
8. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A. Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227 [Abstract] [Full Text] [Related]
9. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy. Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N. Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065 [Abstract] [Full Text] [Related]
10. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA. Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156 [Abstract] [Full Text] [Related]
11. Accuracy of sentinel lymph node biopsy for the assessment of axillary status in patients with early (T1) breast carcinoma. Gurleyik G, Aker F, Sekmen U, Saglam A. J Coll Physicians Surg Pak; 2005 Nov; 15(11):697-700. PubMed ID: 16300705 [Abstract] [Full Text] [Related]
12. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node. Beriwal S, Soran A, Kocer B, Wilson JW, Ahrendt GM, Johnson R. Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225 [Abstract] [Full Text] [Related]
13. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Saidi RF, Dudrick PS, Remine SG, Mittal VK. Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910 [Abstract] [Full Text] [Related]
14. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, Tuzlali S, Mudun A. Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900 [Abstract] [Full Text] [Related]
15. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953 [Abstract] [Full Text] [Related]
16. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Cancer; 2007 Apr 01; 109(7):1255-63. PubMed ID: 17330229 [Abstract] [Full Text] [Related]
17. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG. J Clin Oncol; 2008 May 01; 26(13):2093-8. PubMed ID: 18445838 [Abstract] [Full Text] [Related]
18. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. J Am Coll Surg; 2009 Mar 01; 208(3):333-40. PubMed ID: 19317993 [Abstract] [Full Text] [Related]
19. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M. Breast J; 2008 Mar 01; 14(6):551-5. PubMed ID: 19000054 [Abstract] [Full Text] [Related]
20. Histopathologic analysis of sentinel lymph nodes in breast carcinoma. Hsieh PP, Ho WL, Yeh DC, Liu TJ, Wu CC, Lin JH, Wang SJ. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct 01; 63(10):744-50. PubMed ID: 11076431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]